Abstract
Background: Mycosis fungoides (MF) and Sézary syndrome (SS) are the most frequent epidermotropic cutaneous T-cell lymphomas (CTCL), both originating from CD4+ lymphocytes. There is no curative treatment for these orphan diseases, healing is rare and 25% may progress to higher stage disease. Although the malignant and reactive lymphocytes were studied extensively, little is known about the role of the dermal-epidermal microenvironment in MF and SS. The group of Hodak et al proposed an important role of dermal fibroblasts, but our knowledge on other dermal components is poor.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.